表紙
市場調查報告書

藥物輸送技術的全球市場:2019年∼2029年的預測

Drug Delivery Technologies Market Forecast 2019-2029: Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines

出版商 Visiongain Ltd 商品編碼 233148
出版日期 內容資訊 英文 180 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
藥物輸送技術的全球市場:2019年∼2029年的預測 Drug Delivery Technologies Market Forecast 2019-2029: Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines
出版日期: 2019年02月27日內容資訊: 英文 180 Pages
簡介

本報告涵括全球藥物輸送技術市場,提供主要的藥物輸送技術,次級市場及主要國家市場的趨勢及預測,主要企業的簡介,SWOT分析及專家的見解彙整。

第1章 報告概要

第2章 藥物輸送技術:簡介

  • 藥物輸送技術 (DDT) :為了改善傳統治療藥的策略
  • 全球藥物輸送技術市場:給藥手段
  • 美國的法規
  • 生技藥品 (生物醫藥品)
  • 市場定義

第3章 藥物輸送技術:全球市場

  • 全球藥物輸送技術市場
  • 全球藥物輸送技術市場預測
  • 藥物輸送技術:促進要素、阻礙要素
  • 生技藥品:藥物輸送技術的促進成長要素
    • 全球生技藥品市場預測
    • 生技藥品的主要級
    • 單株抗體:生技藥品的最大部門
    • 胰島素注射液:主要的治療蛋白質市場區隔
    • 肝炎治療的干擾素產品
  • 疫苗:未滿足需求的應對
    • 全球疫苗市場預測

第4章 藥物輸送技術的次級市場

  • 全球藥物輸送技術市場:各次級市場
  • 各市場區隔的市場佔有率的變化預測
  • 口服給藥技術
    • 口服給藥技術市場預測
    • 趨勢、發展
    • 口服給藥技術:促進要素、抑制因素
  • 吸入給藥技術
  • 注射/植入給藥技術
  • 經皮給藥技術
  • 點眼藥給藥技術
  • 經鼻/口腔給藥技術

第5章 全球藥物輸送技術市場:各地區的預測

  • 概要
  • 各地區的市場佔有率

第6章 北美的藥物輸送技術市場預測

  • 概要
  • 各國市場佔有率
  • 美國市場
  • 加拿大市場
  • 墨西哥市場

第7章 南美的藥物輸送技術市場預測

  • 概要
  • 各國市場佔有率
  • 巴西市場
  • 其他

第8章 歐洲的藥物輸送技術市場預測

  • 概要
  • 各國市場佔有率
  • 德國市場
  • 法國市場
  • 英國市場
  • 義大利市場
  • 西班牙市場
  • 其他

第9章 亞太地區的藥物輸送技術市場預測

  • 概要
  • 各國市場佔有率
  • 日本市場
  • 中國市場
  • 印度市場
  • 澳洲市場
  • 韓國市場
  • 其他

第10章 全球及其他藥物輸送技術市場預測

  • 概要
  • 各國市場佔有率
  • 中東市場
  • 非洲市場

第11章 藥物輸送技術市場上的主要企業

  • Alkermes
  • 3M
  • Becton Dickinson and Company
  • Intercell AG
  • Altea Therapeutics Corporation
  • Antares Pharma
  • pSivida
  • Applied Pharma Research
  • Ethypharm
  • Glycologic
  • NanoPass Technologies

第12章 藥物輸送技術市場定性分析

  • 藥物輸送技術市場SWOT分析
  • 優勢
  • 弱點
  • 機會
  • 威脅

第13章 結論

  • 全球藥物輸送技術市場
    • 目前主要藥物輸送技術區分
    • 關注的藥物輸送技術企業
    • 目前地區市場
  • 全球藥物輸送技術市場預測
  • 藥物輸送技術市場未來

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: PHA0356

The Drug Delivery Technologies market is estimated to grow at a CAGR of 8.3% in the first half of the forecast period. The Oral Drug Delivery Technologies submarket held 50% of this market in 2018.

How this report will benefit you

Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you will find 180-page report and you will receive 60 tables and 68 figures - all unavailable elsewhere.

The 180-page report provides clear detailed insight into the Drug Delivery Technologies market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Drug Delivery Technologies market forecasts from 2019-2029.

Drug Delivery Technologies submarket forecasts from 2019-2029 covering:

  • Oral Drug Delivery Technology
  • Inhalable Drug Delivery Technology
  • Injectable/Implantable Drug Delivery Technology
  • Transdermal Drug Delivery Technology
  • Ocular Drug Delivery Technology
  • Nasal/Buccal Drug Delivery Technology

This report discusses the drivers and restraints of each submarket.

Drug Delivery Technologies Market regional and national market forecasts from 2019-2029, covering:

  • North America: US, Canada, Mexico
  • Europe: Germany, France, UK, Italy, Spain, Rest of Europe
  • Asia-Pacific: China, Japan, India, Australia, South Korea, Rest of Asia-Pacific
  • Latin America: Brazil and Rest of Latin America
  • Rest of the World: Middle East, Africa

Assessment of the leading companies in the Drug Delivery Technologies market:

  • 3M
  • Alkermes PLC
  • Altea Therapeutics Corporation
  • Antares Pharma Inc.
  • Applied Pharma Research S.A. (APR)
  • Becton, Dickinson & Company
  • Ethypharm SA
  • Glycologic Limited
  • Intercell AG
  • NanoPass Technologies Ltd.
  • pSivida

SWOT analysis of the drug delivery technologies market.

Visiongain's study is intended for anyone requiring commercial analyses for the Drug Delivery Technologies Market and leading companies. You find data, trends and predictions.

Buy our report today Drug Delivery Technologies Market Forecast 2019-2029: Oral, Inhalable, Injectable/Implantable, Transdermal, Ocular, Nasal/Buccal Drug Delivery Technologies, Biologics, Vaccines.

Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Drug Delivery Technology Market Overview
  • 1.2. Global Drug Delivery Technologies Market Segmentation
  • 1.3. Why You Should Read This Report
  • 1.4. How This Report Delivers
  • 1.5. Key Questions Answered by This Analytical Report
  • 1.6. Who Is This Report For?
  • 1.7. Methodology
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Drug Delivery Technologies: An Introduction

  • 2.1. Drug Delivery Technologies: Strategies to Improve Existing Drugs
  • 2.2. The Global Drug Delivery Technology Market: Methods of Administration
    • 2.2.1. The Biopharmaceutics Classification System and Using Better Tools to Model Drug Absorption
    • 2.2.2. Sustained/Controlled Release Systems
    • 2.2.3. Oral Drug Delivery: Swallowing Drugs to Reach a Target
    • 2.2.4. Pulmonary Delivery: Delivered by Inhalation
    • 2.2.5. Injection as a Route of Drug Delivery
    • 2.2.6. Transdermal Delivery: More Patient-Friendly
    • 2.2.7. Various Transmucosal Delivery Routes for Delivery
    • 2.2.8. Ocular Delivery: Overcoming Unique Barriers
  • 2.3. Regulation in the US
    • 2.3.1. Regulation of Combination Products
    • 2.3.2. FDA Guidelines for Injectors
  • 2.4. Biopharmaceuticals
    • 2.4.1. An Introduction to the Biological Drugs Market
    • 2.4.2. Biologics: A Rising Drugs Market
    • 2.4.3. Biologics with Associated Drug Delivery Technologies
    • 2.4.4. PEGylated Interferons
    • 2.4.5. Stiff Competition in Insulin Market Stimulating Investment in Drug Delivery Technologies
    • 2.4.6. The Main Challenges Facing Biological Drug Delivery
  • 2.5. Market Definition

3. Drug Delivery Technology: Global Market Forecast 2019-2029

  • 3.1. The Global Drug Delivery Technology Market in 2018
  • 3.2. The Global Drug Delivery Technology Market Forecast 2019-2029
  • 3.3. Drug Delivery Technology: Drivers and Restraints 2019-2029
  • 3.4. Biologics: A Driver for Growth in Drug Delivery Technologies
    • 3.4.1. The Global Biological Drugs Market Forecast
    • 3.4.2. Leading Classes of Biological Drugs
    • 3.4.3. Monoclonal Antibodies: Largest Sector in Biologics
    • 3.4.4. Human insulin: Leading the Therapeutic Protein Segment
    • 3.4.5. Interferon Products for the Treatment of Hepatitis
  • 3.5. Vaccines: Meeting the Unmet Needs
    • 3.5.1. The Global Vaccines Market Forecast

4. Drug Delivery Technologies: Submarkets Forecast 2019-2029

  • 4.1. The Global Drug Delivery Technology Market by Submarkets
  • 4.2. How Will Segmental Market Shares Change to 2028?
  • 4.3. Oral Drug Delivery Technology
    • 4.3.1. Oral Drug Delivery Technology Market Forecast 2019-2029
    • 4.3.2. Trends and Developments
      • 4.3.2.1. Delivering APIs to the Colon
      • 4.3.2.2. Google Investing in Robotic Pill
    • 4.3.3. Oral Drug Delivery Technologies: Drivers and Restraints 2019-2029
  • 4.4. Inhalable Drug Delivery Technology
    • 4.4.1. Inhalable Drug Delivery Technology Market Forecast 2019-2029
    • 4.4.2. Trends and Developments
      • 4.4.2.1. Inhalable Liposomal Antibiotics to Penetrate Biofilms
      • 4.4.2.2. Condensation Aerosol Generated by Heat
      • 4.4.2.3. Is Inhaled Insulin Marketable?
    • 4.4.3. Inhalable Drug Delivery Technologies: Drivers and Restraints 2019-2029
  • 4.5. Injectable/Implantable Delivery Technology
    • 4.5.1. Injectable/Implantable Delivery Technology Market Forecast 2019-2029
    • 4.5.2. Trends and Developments
      • 4.5.2.1. Ultrasound Activated Targeted Drug Delivery
      • 4.5.2.2. Intradermal Vaccine Delivery
      • 4.5.2.3. First Flu Vaccine Jet Injector Approved in the US
    • 4.5.3. Injectable/Implantable Delivery Technologies: Drivers and Restraints 2019-2029
  • 4.6. Transdermal Drug Delivery Technology
    • 4.6.1. Transdermal Drug Delivery Technology Market Forecast 2019-2029
    • 4.6.2. Trends and Developments
      • 4.6.2.1. Iontophoretic Transdermal Patch for Migraine Approved in the US
      • 4.6.2.2. Microneedle Patch for Vaccine Delivery
      • 4.6.2.3. Ultrasonic Waveforms to Enlarge Skin Pores
  • 4.7. Ocular Drug Delivery Technology
    • 4.7.1. Ocular Drug Delivery Technology Market Forecast 2019-2029
    • 4.7.2. Trends and Developments
      • 4.7.2.1. Non-Surgical Microinjection to Retina and Choroid to be used for Gene Therapy
  • 4.8. Nasal/Buccal Drug Delivery Technology
    • 4.8.1. Nasal/Buccal Drug Delivery Technology Market Forecast 2019-2029
    • 4.8.2. Trends and Developments
      • 4.8.2.1. Nasal Spray with Live Attenuated Influenza Vaccine
      • 4.8.2.2. Mucosal Vaccine Delivered through the Nose or Mouth
      • 4.8.2.3. Buccal Insulin Spray in Clinical Trials

5. Global Drug Delivery Technologies Market by Region: Forecast 2019-2029

  • 5.1. Overview: Global Drug Delivery Technologies Market, by Region
  • 5.2. Market Share of Global Drug Delivery Technologies Segments by Region

6. North American Drug Delivery Technologies Market: Forecast 2019-2029

  • 6.1. Overview: North American Drug Delivery Technologies Market
    • 6.1.1. The North American Drug Delivery Technologies Market Forecast: 2019-2029
  • 6.2. Market Share of North American Drug Delivery Technologies Segments by Country
  • 6.3. The US Drug Delivery Technologies Market: 2019-2029
    • 6.3.1. Eli Lilly to Establish Drug Delivery Centre
    • 6.3.2. The US Drug Delivery Technologies Market Forecast: 2019-2029
  • 6.4. The Canadian Drug Delivery Technologies Market: 2019-2029
    • 6.4.1. The Canadian Drug Delivery Technologies Market Forecast: 2019-2029
  • 6.5. The Mexican Drug Delivery Technologies Market: 2019-2029
    • 6.5.1. The Mexican Drug Delivery Technologies Market Forecast: 2019-2029

7. Latin American Drug Delivery Technologies Market: Forecast 2019-2029

  • 7.1. Overview: Latin American Drug Delivery Technologies Market 2018
    • 7.1.1. The Latin American Drug Delivery Technologies Market Forecast: 2019-2029
  • 7.2. Market Share of Latin American Drug Delivery Technologies Segments by Country
  • 7.3. The Brazilian Drug Delivery Technologies Market: 2019-2029
    • 7.3.1. The Brazilian Drug Delivery Technologies Market Forecast: 2019-2029
  • 7.4. The Rest of Latin America Drug Delivery Technologies Market: 2019-2029
    • 7.4.1. The Rest of Latin America Drug Delivery Technologies Market Forecast: 2019-2029

8. European Drug Delivery Technologies Market: Forecast 2019-2029

  • 8.1. Overview: European Drug Delivery Technologies Market 2018
    • 8.1.1. The European Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.2. Market Share of European Drug Delivery Technologies Segments by Country
  • 8.3. The German Drug Delivery Technologies Market: 2019-2029
    • 8.3.1. The German Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.4. The French Drug Delivery Technologies Market: 2019-2029
    • 8.4.1. The French Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.5. The UK Drug Delivery Technologies Market: 2019-2029
    • 8.5.1. The UK Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.6. The Italian Drug Delivery Technologies Market: 2019-2029
    • 8.6.1. The Italian Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.7. The Spanish Drug Delivery Technologies Market: 2019-2029
    • 8.7.1. The Spanish Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.8. The Russian Drug Delivery Technologies Market: 2019-2029
    • 8.8.1. The Russian Drug Delivery Technologies Market Forecast: 2019-2029
  • 8.9. The Rest of European Drug Delivery Technologies Market: 2019-2029
    • 8.9.1. The Rest of European Drug Delivery Technologies Market Forecast: 2019-2029

9. Asia-Pacific Drug Delivery Technologies Market: Forecast 2019-2029

  • 9.1. Overview: Asia-Pacific Drug Delivery Technologies Market 2018
    • 9.1.1. Asia-Pacific Drug Delivery Technologies Market Forecast: 2019-2029
  • 9.2. Market Share of Asia-Pacific Drug Delivery Technologies Segments by Country
  • 9.3. The Japanese Drug Delivery Technologies Market: 2019-2029
    • 9.3.1. The New Sakigake Designation System May Accelerate Innovative Drug Development
    • 9.3.2. The Japanese Drug Delivery Technologies Market Forecast: 2019-2029
  • 9.4. The Chinese Drug Delivery Technologies Market: 2019-2029
    • 9.4.1. The Chinese Drug Delivery Technologies Market Forecast: 2019-2029
  • 9.5. The Indian Drug Delivery Technologies Market: 2019-2029
    • 9.5.1. The Indian Drug Delivery Technologies Market Forecast: 2019-2029
  • 9.6. The Australian Drug delivery technologies Market: 2019-2029
    • 9.6.1. The Australian Drug Delivery Technologies Market Forecast: 2019-2029
  • 9.7. South-Korean Drug Delivery Technologies Market: 2019-2029
    • 9.7.1. South-Korean Drug Delivery Technologies Market Forecast: 2019-2029
  • 9.8. The Rest of Asia-Pacific Drug Delivery Technologies Market: 2019-2029
    • 9.8.1. The Rest of Asia-Pacific Drug Delivery Technologies Market Forecast: 2019-2029

10. Rest of the World Drug Delivery Technologies Market Forecast: 2019-2029

  • 10.1. Overview: Rest of the World Drug Delivery Technologies Market 2018
    • 10.1.1. The Rest of the World Drug Delivery Technologies Market Forecast: 2019-2029
  • 10.2. Market Share of Rest of the World Drug delivery technologies Segments by Country
  • 10.3. The Middle-Eastern Drug Delivery Technologies Market: 2019-2029
    • 10.3.1. The Middle-Eastern Drug Delivery Technologies Market Forecast: 2019-2029
  • 10.4. The African Drug Delivery Technologies Market: 2019-2029
    • 10.4.1. The African Drug Delivery Technologies Market Forecast: 2019-2029

11. Leading Companies in the Drug Delivery Technology Market

  • 11.1. Alkermes: Focused on Extended and Controlled Release
    • 11.1.1. Alkermes PLC
    • 11.1.2. Alkermes PLC: Company Overview
    • 11.1.3. Alkermes PLC: Recent Developments
  • 11.2. 3M
    • 11.2.1. 3M: Company Overview
    • 11.2.2. 3M Company: Product Portfolio
    • 11.2.3. 3M Company: Recent Developments
  • 11.3. Becton, Dickinson & Company: A History of Hypodermic Needles and Syringes
    • 11.3.1. Becton, Dickinson & Company: Company Overview
    • 11.3.2. Becton, Dickinson & Company: Recent Developments
  • 11.4. Intercell AG
    • 11.4.1. Intercell AG: Company Overview
  • 11.5. Altea Therapeutics Corporation
    • 11.5.1. Altea Therapeutics Corporation: Company Overview
  • 11.6. Antares Pharma: Leading the Needle-Free Injector Market
    • 11.6.1. Antares Pharma Inc.: Company Overview
    • 11.6.2. Antares Pharma Inc.: Recent Developments
  • 11.7. pSivida:
    • 11.7.1. pSivida Corporation: Company Overview
    • 11.7.2. pSivida Corporation: Recent Developments
  • 11.8. Applied Pharma Research (APR)
    • 11.8.1. Applied Pharma Research S.A.: Company Overview
    • 11.8.2. Applied Pharma Research S.A.: Recent Developments
  • 11.9. Ethypharm
    • 11.9.1. Ethypharm S.A.: Company Overview
  • 11.10. Glycologic
    • 11.10.1. Glycologic Limited: Company Overview
  • 11.11. NanoPass Technologies
    • 11.11.1. NanoPass Technologies Ltd.: Company Overview
    • 11.11.2. NanoPass Technologies Ltd.: Recent Developments

12. Qualitative Analysis of the Drug Delivery Technology Market 2019-2029

  • 12.1. SWOT Analysis of the Drug Delivery Technology Market
  • 12.2. Strengths
    • 12.2.1. Increasing Competition and Patent Expiry in the Biologics Market
    • 12.2.2. The Rise of Biosimilars
    • 12.2.3. Increasing Global Diabetic Population
  • 12.3. Weaknesses
    • 12.3.1. Risk-Conscious Regulatory Bodies Will Make Approval Difficult
    • 12.3.2. Companies Need to Develop a More Liberal Mindset
  • 12.4. Opportunities
    • 12.4.1. Nanotechnology: Innovations That Will Benefit Drug Delivery
    • 12.4.2. Possible New Delivery Methods for Insulin
  • 12.5. Threats
    • 12.5.1. Increasing Specificity of Drug Development Poses Challenges to Speciality Drug Delivery Companies
    • 12.5.2. Cost Effective Solutions May Not Be Available

13. Conclusions

  • 13.1. The Global Drug Delivery Technologies Market in 2018
    • 13.1.1. Current Leading Drug Delivery Technology Segments
    • 13.1.2. Notable Drug Delivery Technology Companies
    • 13.1.3. Current Regional Markets
  • 13.2. Global Drug Delivery Technology Market Forecast 2019-2029
  • 13.3. The Future of the Drug Delivery Technology Market
    • 13.3.1. Transdermal and Injectable Drug Delivery Technologies Set for High Growth
    • 13.3.2. Biologics and Biosimilars to Drive Market Growth
  • Appendices
  • Glossary
  • Associated Visiongain Reports
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Visiongain report evaluation form

List of Tables

  • Table 2.1: The Biopharmaceutics Classification System, Classification and Description
  • Table 2.2: Top 5 Biologics by Sales ($bn), 2018
  • Table 3.1: The Global Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 3.2: Global Biological Drugs Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 3.3: Global Vaccines Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.1: The Global Drug Delivery Technology Market by Submarkets: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.2: Leading Drug Delivery Market Segments: Share (%), 2018, 2023, and 2029
  • Table 4.3: Oral Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.4: Inhalable Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.5: Insulin Inhalers Withdrawal from the Market or Pipeline, 2017
  • Table 4.6: Injectable/Implantable Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.7: Transdermal Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.8: Ocular Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 4.9: Nasal/Buccal Drug Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2019-2029
  • Table 5.1: Global Drug Delivery Technologies Market by region: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 6.1: North American Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 6.2: The US Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 6.3: The Canadian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 6.4: The Mexican Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 7.1: Latin American Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 7.2: The Brazilian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 7.3: The Rest of Latin America Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.1: European Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.2: The German Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.3: The French Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.4: The UK Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.5: The Italian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.6: The Spanish Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.7: The Russian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 8.8: The Rest of European Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.1: Asia-Pacific Drug Delivery Technologies Market by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.2: The Japanese Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.3: The Chinese Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.4: The Indian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.5: The Australian Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.6: South-Korean Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 9.7: The Rest of Asia-Pacific Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 10.1: Rest of the world Drug Delivery Technologies Market, by country: Revenue ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 10.2: The Middle-Eastern Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 10.3: The African Drug Delivery Technologies Market: Revenue Forecast ($m), AGR (%), Market Share (%) and CAGR (%), 2019-2029
  • Table 11.1: Akermes PLC: Company Overview
  • Table 11.2: Alkermes PLC: Recent Developments
  • Table 11.3: 3M: Company Overview
  • Table 11.4: 3M: Product Portfolio
  • Table 11.5: 3M Company: Recent Developments
  • Table 11.6: Becton, Dickinson & Company: Company Overview
  • Table 11.7: Becton, Dickinson & Company: Recent Developments
  • Table 11.8: Intercell AG: Company Overview
  • Table 11.9: Altea Therapeutics Corporation: Company Overview
  • Table 11.10: Antares Pharma Inc.: Company Overview
  • Table 11.11: Antares Pharma Inc.: Recent Developments
  • Table 11.12: pSivida Corporation: Company Overview
  • Table 11.13: pSivida Corporation: Recent Developments
  • Table 11.14: Applied Pharma Research S.A.: Company Overview
  • Table 11.15: Applied Pharma Research S.A.: Recent Developments
  • Table 11.16: Ethypharm S.A.: Company Overview
  • Table 11.17: Glycologic Limited: Company Overview
  • Table 11.18: NanoPass Technologies Ltd.: Company Overview
  • Table 11.19: NanoPass Technologies Ltd.: Recent Developments
  • Table 12.1 SWOT Analysis of the Drug Delivery Technology Market, 2019-2029

List of Figures

  • Figure 1.1: Global Drug Delivery Technologies Market Segmentation Overview 2018
  • Figure 3.1: The Global Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 3.2: Drug Delivery Technologies: Market Drivers and Restraints 2019-2029
  • Figure 3.3: The Global Biological Drugs Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.1: Leading Drug Delivery Market Segments: CAGR (%), 2019-2024
  • Figure 4.2: Leading Drug Delivery Market Segments: CAGR (%), 2024-2029
  • Figure 4.3: Leading Drug Delivery Market Segments: CAGR (%), 2019-2029
  • Figure 4.4: Market Shares (%) of Leading Drug Delivery Market Segments, 2018
  • Figure 4.5: Market Shares (%) of Leading Drug Delivery Market Segments, 2029
  • Figure 4.6: Oral Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.7: Oral Drug Delivery Technologies: Drivers and Restraints 2019-2029
  • Figure 4.8: Inhalable Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.9: Inhalable Drug Delivery Technologies: Drivers and Restraints 2019-2029
  • Figure 4.10: Injectable/Implantable Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.11: Injectable/implantable Drug Delivery Technologies: Drivers and Restraints 2019-2029
  • Figure 4.12: Transdermal Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.13: Ocular Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 4.14: Nasal/Buccal Drug Delivery Technology Market: Revenue ($m) and AGR (%), 2019-2029
  • Figure 5.1: Global Drug Delivery Technologies Market by region: Market Share (%) 2018
  • Figure 5.2: Global Drug Delivery Technologies Market by region: Market Share (%) 2029
  • Figure 6.1: North American Drug Delivery Technologies Market by country: Market Share (%) 2018
  • Figure 6.2: North American Drug Delivery Technologies Market by country: Market Share (%) 2029
  • Figure 6.3: North American Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 6.4: The US Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 6.5: The Canadian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 6.6: The Mexican Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 7.1: Latin American Drug Delivery Technologies Market by country: Market Share (%) 2018
  • Figure 7.2: Latin American Drug Delivery Technologies Market by country: Market Share (%)2029
  • Figure 7.3: Latin American Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 7.4: The Brazilian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 7.5: The Rest of Latin America Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.1: European Drug Delivery Technologies Market by Country: Market Share (%) 2018
  • Figure 8.2: European Drug Delivery Technologies Market by Country: Market Share (%) 2029
  • Figure 8.3: European Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.4: The German Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.5: The French Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.6: The UK Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.7: The Italian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.8: The Spanish Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.9: The Russian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 8.10: The Rest of European Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.1: Asia-Pacific Drug Delivery Technologies Market by country: Market Share (%)2018
  • Figure 9.2: Asia-Pacific Drug Delivery Technologies Market, by country: Market Share (%)2029
  • Figure 9.3: Asia-Pacific Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.4: The Japanese Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.5: The Chinese Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.6: The Indian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.7: The Australian Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.8: South-Korean Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 9.9: The Rest of Asia-Pacific Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 10.1: Rest of the World Drug Delivery Technologies Market by Country: Market Share (%) 2018
  • Figure 10.2: Rest of the World Drug Delivery Technologies Market by Country: Market Share (%) 2029
  • Figure 10.3: Rest of the World Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 10.4: The Middle-Eastern Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 10.5: The African Drug Delivery Technologies Market Revenue Forecast ($m), AGR (%), 2019-2029
  • Figure 11.1: Alkermes PLC: Revenue ($m), 2013-2017
  • Figure 11.2: Alkermes PLC: Geographical Presence Share (%), 2017
  • Figure 11.3: 3M: Revenue ($m), 2013-2017
  • Figure 11.4: 3M: Product Segments Share (%), 2017
  • Figure 11.5: 3M: Geographical Presence Share (%), 2017
  • Figure 11.6: Becton, Dickinson & Company: Revenue ($m), 2013-2017
  • Figure 11.7: Becton, Dickinson & Company: Geographical Presence Share (%), 2017
  • Figure 11.8: Becton, Dickinson & Company: Segment Share (%), 2017
  • Figure 11.9: Antares Pharma Inc.: Revenue ($m), 2013-2017
  • Figure 11.10: Antares Pharma Inc.: Segment Share (%), 2017
  • Figure 11.11: Antares Pharma Inc.: Segment Share (%), 2017
  • Figure 11.12: pSivida Corporation: Revenue ($m), 2013-2017
  • Figure 11.13: pSivida Corporation: Product Segments Share (%), 2017

COMPANIES LISTED:

  • 3M
  • Alexza Pharmaceuticals
  • Alkermes
  • Altea Therapeutics Corporation
  • Alza
  • Antares Pharma Inc.
  • Applied Pharma Research S.A. (APR)
  • Aradigm
  • AstraZeneca
  • Bayer HealthCare Pharmaceuticals
  • Becton, Dickinson and Company
  • Biogen Idec
  • Bristol-Myers Squibb
  • C.R. Bard, Inc.
  • Caesarea Medical Electronics (CME)
  • CareFusion Corporation
  • Cima Labs
  • Clearside Biomedical
  • Cosmo Pharmaceuticals
  • CRISI Medical Systems
  • Eli Lilly
  • Ethypharm SA
  • Ferrer
  • Flamel
  • Genentech
  • Generex
  • Glycologic Limited
  • Google
  • IDRI
  • ImmusanT
  • Innovent Biologics
  • Insmed
  • Intercell AG
  • iScience Interventional Corporation
  • J&J
  • MannKind
  • Medimetrics
  • MedImmune
  • Merck Serono
  • Mucosis
  • NanoPass Technologies Ltd.
  • Nektar Therapeutics
  • NHTherapeutics
  • Nitto Denko
  • Novo Nordisk
  • NuPathe
  • Oramed Pharmaceuticals
  • Pari Pharma
  • Pfizer
  • PharmaJet
  • Phoenix Solutions AS
  • pSivida
  • Rani Therapeutics
  • Renhe Group
  • Sandoz
  • Sanofi-Aventis
  • Santen
  • Spark Therapeutics
  • Teva
  • Transdermal Specialties
  • VentureHealth

Organizations Mentioned in the Report:

  • Australia Institute of Health and Welfare
  • Bill & Melinda Gates Foundation
  • Center for Disease Control and Prevention (CDC)
  • Center for Biologics Evaluation and Research (CBER)
  • Center for Devices and Radiological Health (CDRH)
  • Center for Drug Evaluation and Research (CDER)
  • Emory University School of Medicine
  • Food and Drug Administration (FDA)
  • Georgia Institute of Technology
  • International Diabetes Federation
  • Japan's Ministry of Health, Labour, and Welfare (MHLW)
  • JDRF
  • The Center for Drug Evaluation (CDE)
  • The European Medicines Agency (EMA
  • World Health Organization (WHO)
Back to Top